Prevention of diabetic nephropathy

Hospital Practice

Volumn 32, Issue 2, 1997, Pages 129-140

  Materson, Barry J ^a,b   Preston, Richard A ^a,b,c  

^a UNIVERSITY OF MIAMI   (United States)

^b UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; CALCIUM ANTAGONIST; CAPTOPRIL; DIHYDROPYRIDINE DERIVATIVE; DILTIAZEM; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENALAPRIL; NIFEDIPINE; VERAPAMIL;

ARTICLE; BLOOD PRESSURE REGULATION; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION; HUMAN; HUMAN CELL; HUMAN TISSUE; INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PROTEIN RESTRICTION;

EID: 0031056919     PISSN: 87502836     EISSN: None     Source Type: Journal    
DOI: 10.1080/21548331.1997.11443426     Document Type: Article

References (12)

1. Brenner BM, Milford EL: Nephron underdosing: A programmed case of chronic renal allograft failure. Am J Kidney Dis 21:66, 1993
2. Diabetes Control and Complications Trial Research Group: The effects of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 329:977, 1993
3. Goodfriend TL, Elliott ME, Catt KJ: Angiotensin receptors and their antagonists. N Engl J Med 334:1649, 1996
4. Gray H, O'Rahilly S: Toward improved glycemic control in diabetes: What's on the horizon? Arch Intern Med 155:1137, 1995
5. Klag MJ et al: Blood pressure and end-stage renal disease in men. N Engl J Med 334:13, 1996
6. Klahr S et al: The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease: Modification of Diet in Renal Disease Study Group. N Engl J Med 330:877, 1994
7. Laffel LM, McGill JB, Gans DJ: The beneficial effect of anglotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria: North American Microalbuminuria Study Group. Am J Med 99:497, 1995
8. Lewis EJ et al: The effect of angiotensin-converting enzyme inhibition on diabetic nephropathy: The Collaborative Study Group. N Engl J Med 329:1456, 1993
9. Nelson RG et al: Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus: Diabetic Renal Disease Study Group. N Engl J Med 335:1636, 1996
10. Neuringer JR, Brenner BM: Hemodynamic theory of progressive renal disease: A 10-year update in brief review. Am J Kidney Dis 22:98, 1993
11. Ravid M et al: Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann Int Med 118:577, 1993
12. Ravid M et al: Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus: A 7-year follow-up study. Arch Int Med 156:286, 1996